Schering-Plough's peginterferon (PEG IFN)- -2b plus ribavirin [Peg-Intron plus Rebetol] has been granted priority review status in Japan for a new indication

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1495, 2005-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract